Iodinated contrast reaction, premedication & re-exposure

Decides whether corticosteroid premedication is indicated before re-exposing a patient to iodinated contrast, and which ACR regimen fits the setting. Separates allergic-like from physiologic index reactions, rules out the non-indications (shellfish/iodine, other-class contrast, atopy), and routes by urgency to the 12-13 hour oral regimen, the accelerated 4-5 hour IV regimen, or an explicit no-effective-prophylaxis path with resuscitation readiness.

Evidence tier: Guideline-derived.

Decision points

What type of prior contrast reaction?
How severe was the index reaction?
Is there time for the 12-13 hour oral regimen?

Do-not-miss pitfalls

Shellfish and "iodine" allergy are NOT indications for premedication. ACR names this explicitly. Iodine is an element in thyroid hormone and dietary protein, there is no iodine cross-reactivity mechanism, and acting on the myth delays imaging for no benefit.
Physiologic reactions (nausea, vomiting, warmth, metallic taste, vasovagal) are not allergic-like and are NOT mitigated by premedication. A reaction of this type after premedication does not even count as a breakthrough reaction.
Any regimen shorter than 4-5 hours, oral or IV, has no demonstrated efficacy. A single steroid dose one hour before the scan is reassurance theatre; ACR lists it only as a last-resort emergent option and says plainly it has no evidence of efficacy.
Premedication does not prevent all reactions. Patients premedicated for a prior contrast reaction still break through at about 2.1%, roughly 3-4 times the background rate, and about 81% of breakthrough reactions match the severity of the index reaction.
The delay is a real harm. Thirteen-hour oral prophylaxis in high-risk inpatients was associated with a median 25-hour longer stay, 25-hour longer time to CT, more hospital-acquired infection, and higher cost, which can outweigh the benefit in vulnerable patients.
The number needed to premedicate is very high: roughly 69 to prevent a reaction of any severity, 569 to prevent a severe reaction, and an estimated 50,000 to prevent a lethal one. Weigh that against the delay before reflexively ordering it.
Substituting a different iodinated agent, ideally one the patient has tolerated, ranks above premedication as a mitigation strategy, but is only possible if the culprit agent was documented by name. Record the agent, not just "dye".
A prior SEVERE reaction is a relative contraindication to the same contrast class, not merely an indication to premedicate harder. Escalate to a joint radiology/allergy decision and look hard for an alternative.
Intradermal skin testing with contrast media has not been shown useful for predicting reaction risk, and prior exposure is not required, a severe reaction can happen on first-ever exposure.
Premedication evidence for gadolinium-based agents and for oral contrast is extrapolated from intravascular iodinated data; no studies evaluate efficacy in those settings.

Evidence & citations

Clinician decision support. Verify against the cited source. Not a substitute for clinical judgment. 100% on-device; no patient data is stored or transmitted.